Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_1
1
20%
Ph phase_3
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Terminated1
Recruiting1
unknown1
Completed1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 31 (20.0%)
N/A3 (60.0%)

Trials by Status

terminated120%
recruiting120%
unknown120%
completed120%
enrolling_by_invitation120%

Recent Activity

1 active trials
Showing 5 of 5
enrolling_by_invitationnot_applicable

ESWT vs Orthosis in Trigger Finger

NCT06737601
recruitingnot_applicable

NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-sectional Lesions on Motor and Sensory Function Within Six Months After Injury

NCT04474106
unknownnot_applicable

Effects of Clinical Interventions for the Management of Late Start

NCT04628403
completedphase_1

Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT

NCT02400619
terminatedphase_3

Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT)

NCT02068417

Clinical Trials (5)

Showing 5 of 5 trials
NCT06737601Not Applicable

ESWT vs Orthosis in Trigger Finger

Enrolling By Invitation
NCT04474106Not Applicable

NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-sectional Lesions on Motor and Sensory Function Within Six Months After Injury

Recruiting
NCT04628403Not Applicable

Effects of Clinical Interventions for the Management of Late Start

Unknown
NCT02400619Phase 1

Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT

Completed
NCT02068417Phase 3

Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT)

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5